Medindia

X

TruFUSE(R) Minimally Invasive Facet Fusion Procedure Tops 3,000 Spinal Levels

Friday, May 16, 2008 General News J E 4
Advertisement
CLEARWATER, Fla., May 15 minSURG Corporation, a subsidiaryof Orthopedic Development Corporation, announced today that over 6,000TruFUSE(R) dowels have been used to treat chronic facet-oriented back pain orto supplement other procedures. Typically, two dowels are required to fuseeach of the two facet joints in each spinal level. TruFUSE, one of the firstsurgical solutions to treat intractable back pain without precluding otheroptions, has been in limited distribution since late 2006 and achievednationwide distribution in 2008.

According to minSURG CEO James Doulgeris, the company has now trained andcertified over 100 physicians to perform the TruFUSE procedure and isaccredited in over 200 hospitals around the country.

"With nationwide distribution and 300 trained and certified TruFUSErepresentatives now online, we are well positioned to service ourmarketplace," Doulgeris said. "Our comprehensive distribution, demonstratedgood-to-excellent clinical outcomes in over 98% of TruFUSE patients,(1) andstrong interest from the medical community provide a solid foundation to buildupon."

Painful facet joints are cited as the most common cause of chronic backpain, a leading cause of long-term disability. TruFUSE uses specially designedbone dowels to stop facet joints from moving, which is intended to eliminateor dramatically reduce back pain caused by a variety of reasons. TruFUSE isalso used to supplement other back surgeries when more invasive or destructivemeans are not required. The TruFUSE procedure is intended to fuse the facetjoints through a natural healing process for a long-term solution. BecauseTruFUSE causes minimal tissue damage, it does not preclude other options,including non-surgical alternatives, and TruFUSE can be used earlier thanother, more invasive spine fusion methods.

For more information on TruFUSE, please visit the Web site atwww.trufuse.com or call (813) 318-0565 ext. 216.

(1) In a retrospective chart review of 81 patients from 6 unaffiliateddoctors, 80 of 81 patients had "good" to "excellent" results.

SOURCE minSURG Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
MEDEX Global Group Acquires ASI Group
S
RealAge Wins Silver PhAME Award